Literature DB >> 19320594

Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.

Alison M Kesson1, Michael C Bellemore, Timothy J O'Mara, David H Ellis, Tania C Sorrell.   

Abstract

We describe an 8-year-old girl who sustained multiple compound fractures in an accident involving agricultural equipment. She developed Scedosporium prolificans osteomyelitis of the pelvis, septic arthritis of the hip, and myositis of adjacent muscles. The infection progressed, despite extensive surgical debridement and joint washouts with 0.2% polyhexamethylene biguanide; antifungal therapy with caspofungin, terbinafine, and voriconazole; and adjunctive therapy with interferon-gamma. Gradual resolution was achieved after the addition of a novel agent, hexadecylphospocholine (miltefosine), and the continuation of terbinafine and voriconazole. This is the first report of the use of miltefosine as an antifungal agent in the management of severe infection with S. prolificans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320594     DOI: 10.1086/597772

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  In vitro combination of voriconazole and miltefosine against clinically relevant molds.

Authors:  S Imbert; M Palous; I Meyer; E Dannaoui; D Mazier; A Datry; A Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2014-09-08       Impact factor: 5.191

2.  Use of Antifungal Combination Therapy: Agents, Order, and Timing.

Authors:  Melissa D Johnson; John R Perfect
Journal:  Curr Fungal Infect Rep       Date:  2010-05-01

Review 3.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Osteoarticular Infections Following Open or Penetrating Trauma in Children in the Post-Community-Acquired Methicillin-resistant Staphylococcus aureus Era: The Impact of Enterobacter cloacae.

Authors:  J Chase McNeil; Jesus G Vallejo; Kristina G Hultén; Sheldon L Kaplan
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

5.  Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; William R Kirkpatrick; Tania C Sorrell; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2012-11-19       Impact factor: 5.191

6.  Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.

Authors:  Florent Morio; Delphine Horeau-Langlard; Françoise Gay-Andrieu; Jean-Philippe Talarmin; Alain Haloun; Michelle Treilhaud; Philippe Despins; Frédérique Jossic; Laurence Nourry; Isabelle Danner-Boucher; Sabine Pattier; Jean-Philippe Bouchara; Patrice Le Pape; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

Review 7.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

8.  Successful use of locally applied polyhexamethylene biguanide as an adjunct to the treatment of fungal osteomyelitis.

Authors:  Genevieve Walls; Lisa Noonan; Elizabeth Wilson; David Holland; Simon Briggs
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

9.  Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.

Authors:  Duncan Webster; Imran Umar; Imram Umar; George Kolyvas; Juan Bilbao; Marie-Christine Guiot; Kevin Duplisea; Yvonne Qvarnstrom; Govinda S Visvesvara
Journal:  Am J Trop Med Hyg       Date:  2012-08-06       Impact factor: 2.345

10.  Efficacy of Azithromycin and Miltefosine in Experimental Systemic Pythiosis in Immunosuppressed Mice.

Authors:  Erico S Loreto; Juliana S M Tondolo; Francielli P K de Jesus; Camila M Verdi; Carla Weiblen; Maria I de Azevedo; Glaucia D Kommers; Janio M Santurio; Régis A Zanette; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.